Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with combination chemotherapy for peripheral T-cell lymphoma and natural killer cell neoplasms has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer Cell Neoplasms
• Peripheral T-cell Lymphoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-05-07